| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
natriuretic peptide B | 0.513 | 0.808 | 9.9E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
EGF like domain multiple 7 | 0.612 | 0.577 | 5.5E-18 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
angiopoietin 4 | 0.711 | 0.423 | 4.5E-15 |
|
group | 0.010 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
phosphodiesterase 4D | 0.519 | 0.846 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
selenocysteine lyase | 0.530 | 0.731 | 2.3E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
platelet factor 4 variant 1 | 0.760 | 0.462 | 8.2E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
complement factor properdin | 0.573 | 0.692 | 0.69 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
peptidase inhibitor 3 | 0.570 | 0.692 | 0.17 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Pim-1 proto-oncogene, serine/threonine kinase | 0.482 | 0.769 | 0.85 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
phospholipase A2 group IIA | 0.488 | 0.808 | 9.7E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
transmembrane p24 trafficking protein 7 | 0.436 | 0.808 | 0.48 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
sclerostin | 0.474 | 0.808 | 0.87 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
microRNA 423 | 0.566 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 424 | 0.535 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
purinergic receptor P2X 1 | 0.584 | 0.808 | 6.8E-11 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
purinergic receptor P2X 3 | 0.565 | 0.769 | 1.0E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
purinergic receptor P2X 4 | 0.547 | 0.808 | 5.0E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
purinergic receptor P2X 5 | 0.548 | 0.769 | 2.9E-13 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
purinergic receptor P2Y1 | 0.551 | 0.769 | 0.52 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |